Proprietary Platform Technology

How our proprietary technology works:

Sirona Biochem has expertise in the development of carbohydrate-based molecules.

Carbohydrates, or sugar molecules, have broad potential for ground-breaking pharmaceutical and cosmetic development as they play a critical role in most of the major diseases. Carbohydrates are implied in a wide range of biological functions, cell/cell communication, immunity and cancer development. It is thus their central role in the communication between cells and their ability to interact with proteins, hormones, viruses, toxins or bacteria which make carbohydrate-based molecules major candidates for the development of new curative treatments.

However, a major limitation of carbohydrate molecules is their lack of stability. When coming into contact with enzymes in the body, for example, carbohydrate-based molecules can easily break down or become toxic, making them difficult to produce as pharmaceutical products.

Sirona Biochem’s French subsidiary, TFChem, has developed proprietary chemistry that maintains the integrity of carbohydrate-based molecules even after enzyme exposure. Through years of award-winning research, the Company's synthetic chemists have learned how to strengthen the bond of a carbohydrate molecule by strategically placing atoms within the molecule. This technique has yielded many compounds showing promise for the development of therapeutics and cosmetic ingredients.

TFChem's research has demonstrated that applying this chemistry technique can enhance the stability and efficacy of carbohydrate-based molecules. This proprietary chemistry platform allows for the development of new, robust, compounds as well as the ability to improve previously-developed compounds by other companies. Those compounds may have otherwise been put on hold because of the inherent challenges of carbohydrate-based chemistry.